These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Race and renal cell carcinoma stage at diagnosis: an analysis of the Surveillance, Epidemiology, and End Results data. Lin J; Kamamia C; Shriver CD; Zhu K Eur J Cancer Prev; 2019 Jul; 28(4):350-354. PubMed ID: 30376467 [TBL] [Abstract][Full Text] [Related]
3. Re: The Effect of Race and Gender on the Surgical Management of the Small Renal Mass. Klaassen Z; Everett R; Madi R; Terris MK Eur Urol; 2015 Jul; 68(1):163-4. PubMed ID: 26088733 [No Abstract] [Full Text] [Related]
4. Rising incidence of renal cell cancer in the United States. Chow WH; Devesa SS; Warren JL; Fraumeni JF JAMA; 1999 May; 281(17):1628-31. PubMed ID: 10235157 [TBL] [Abstract][Full Text] [Related]
6. Age-period-cohort analysis of renal cell carcinoma in United States adults. Tyson MD; Humphreys MR; Parker AS; Thiel DD; Joseph RW; Andrews PE; Castle EP Urology; 2013 Jul; 82(1):43-7. PubMed ID: 23706585 [TBL] [Abstract][Full Text] [Related]
7. Effect of African-American race on cancer specific mortality differs according to clear cell vs. non-clear cell histologic subtype in metastatic renal cell carcinoma. Marchioni M; Harmouch SS; Nazzani S; Bandini M; Preisser F; Tian Z; Kapoor A; Cindolo L; Briganti A; Shariat SF; Schips L; Karakiewicz PI Cancer Epidemiol; 2018 Jun; 54():112-118. PubMed ID: 29715680 [TBL] [Abstract][Full Text] [Related]
8. Temporal change in risk of metachronous contralateral renal cell carcinoma: influence of tumor characteristics and demographic factors. Rabbani F; Herr HW; Almahmeed T; Russo P J Clin Oncol; 2002 May; 20(9):2370-5. PubMed ID: 11981010 [TBL] [Abstract][Full Text] [Related]
9. Diversity in Renal Mass Data Cohorts: Implications for Urology AI Researchers. Cen HS; Dandamudi S; Lei X; Weight C; Desai M; Gill I; Duddalwar V Oncology; 2024; 102(7):574-584. PubMed ID: 38104555 [TBL] [Abstract][Full Text] [Related]
10. Chronic kidney disease and risk of renal cell carcinoma: differences by race. Hofmann JN; Corley DA; Zhao WK; Colt JS; Shuch B; Chow WH; Purdue MP Epidemiology; 2015 Jan; 26(1):59-67. PubMed ID: 25393631 [TBL] [Abstract][Full Text] [Related]
11. Stat bite: Kidney cancer incidence, 2000-2003. J Natl Cancer Inst; 2006 Sep; 98(17):1181. PubMed ID: 16954470 [No Abstract] [Full Text] [Related]
17. Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations. Callahan CL; Schwartz K; Corley DA; Ruterbusch JJ; Zhao WK; Shuch B; Graubard BI; Rothman N; Chow WH; Silverman DT; Purdue MP; Hofmann JN Cancer Causes Control; 2020 Jan; 31(1):85-93. PubMed ID: 31782041 [TBL] [Abstract][Full Text] [Related]
18. Comparison of time trends in kidney cancer incidence (1973-97) in East Asia, Europe and USA, from cancer incidence in five continents, Vols IV-VIII. Marugame T; Matsuda T Jpn J Clin Oncol; 2008 Jul; 38(7):508-9. PubMed ID: 18664483 [No Abstract] [Full Text] [Related]
19. Physical activity and renal cell carcinoma among black and white Americans: a case-control study. Xiao Q; Liao L; Matthews CE; Chow WH; Davis F; Schwartz K; Purdue M; Hofmann JN; Colt J BMC Cancer; 2014 Sep; 14():707. PubMed ID: 25253394 [TBL] [Abstract][Full Text] [Related]
20. A case-control study of reproductive factors and renal cell carcinoma among black and white women in the United States. Purdue MP; Colt JS; Graubard B; Davis F; Ruterbusch JJ; Digaetano R; Karami S; Wacholder S; Schwartz K; Chow WH Cancer Causes Control; 2011 Nov; 22(11):1537-44. PubMed ID: 21866373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]